Autoantibodies in sarcoidosis: Innocent bystander or promising biomarker for organ involvement?
Analysis of autoantibodies expressed in our case series did not identify a specific autoantibodies pattern in sarcoidosis. Few studies have analyzed autoantibody patterns in sarcoidosis patients and involved smaller populations. In conclusion, our study evaluates a sizable population, and underlines the need for further, larger clinical studies to evaluate possible associations between sarcoidosis and autoimmunity.
Authors
- Elisa Baratella (ORCID: https://orcid.org/0000-0002-1061-9507)
- Michael Hughes (ORCID: https://orcid.org/0000-0003-3361-4909)
- Lucrezia Mondini (ORCID: https://orcid.org/0000-0002-7043-9639)
- Marco Confalonieri (ORCID: https://orcid.org/0000-0002-4791-768X)
- Nicolò Reccardini (ORCID: https://orcid.org/0009-0004-5792-3655)
- Barbara Ruaro (ORCID: https://orcid.org/0000-0001-8990-859X)
- Paola Confalonieri (ORCID: https://orcid.org/0000-0002-7284-5016)
- Mariangela Barbieri
- Liliana Trotta (ORCID: https://orcid.org/0009-0007-6338-598X)
- Francesco Salton (ORCID: https://orcid.org/0000-0002-0864-9766)
- Riccardo Pozzan (ORCID: https://orcid.org/0000-0003-4114-8776)
- Chiara Torregiani (ORCID: https://orcid.org/0000-0001-9110-3029)
- Gianluca Screm
Institutions
- University of Trieste (IT)
- Salford Royal NHS Foundation Trust (GB)
- University of Manchester (GB)
- Ospedale di Cattinara (IT)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-10
- DOI
- https://doi.org/10.36141/svdld.v41i4.16043
- Citations
- 1
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.33